SCHEMBL18875223

SCHEMBL18875223

c1ccc2c(c1)Oc1ccccc1N2c1cc(-c2cc(-c3nc4ccccc4s3)cc(N3c4ccccc4Sc4ccccc43)c2)cc(-c2nc3ccccc3o2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.39
KDM4E B2RXH2 9/20 0.38
SMN1; SMN2 Q16637 8/20 0.38
RAB9A P51151 8/20 0.38
ALDH1A1 P00352 7/20 0.38
NPC1 O15118 7/20 0.38
HPGD P15428 5/20 0.38
NFKB1 P19838 5/20 0.38
NFKB2 Q00653 5/20 0.38
RELA Q04206 5/20 0.38
LMNA P02545 4/20 0.38
MAPT P10636 4/20 0.38
GAA P10253 2/20 0.38
STAT1 P42224 1/20 0.38
GFER P55789 1/20 0.38
HSD17B10 Q99714 4/20 0.37
PKM P14618 3/20 0.37
KMT2A Q03164 8/20 0.37
MEN1 O00255 6/20 0.37
HPSE Q9Y251 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18875219 1.00 TP53 (0.39) TP53KDM4ESMN1; SMN2RAB9AALDH1A1
SCHEMBL18875188 0.94 TP53 (0.43) TP53KDM4ESMN1; SMN2RAB9AALDH1A1
SCHEMBL18875222 0.93 TP53 (0.43) TP53KDM4ESMN1; SMN2RAB9AALDH1A1
SCHEMBL18875259 0.93 TP53 (0.43) TP53KDM4ESMN1; SMN2RAB9AALDH1A1
SCHEMBL18875200 0.91 RAB9A (0.44) TP53KDM4ESMN1; SMN2RAB9AALDH1A1
SCHEMBL18875255 0.91 SMN1; SMN2 (0.43) TP53KDM4ESMN1; SMN2RAB9AALDH1A1
SCHEMBL18875246 0.85 NPC1 (0.41) TP53KDM4ESMN1; SMN2RAB9AALDH1A1
SCHEMBL18875232 0.85 NPC1 (0.41) TP53KDM4ESMN1; SMN2RAB9AALDH1A1
SCHEMBL18875249 0.84 SMN1; SMN2 (0.48) TP53KDM4ESMN1; SMN2RAB9AALDH1A1
SCHEMBL18875152 0.84 RAB9A (0.49) TP53KDM4ESMN1; SMN2RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME WUHAN TIANMA MICROELECTRONICS CO., LTD.SHANGHAI BRANCH (CN) 2017-05-25 US disclosed
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME WUHAN TIANMA MICROELECTRONICS CO., LTD.SHANGHAI BRANCH (CN) 2017-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME OR10J3, PPOX, OR51E2 TP53 4141/4885KDM4E 2416/4885SMN1; SMN2 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.